Atossa Therapeutics (ATOS) Stock More Than Doubled In a Month: What’s The Buzz?

The Atossa Therapeutics Inc (NASDAQ:ATOS) stock has emerged as a major winner so far this month after the stock clocked gains of 114% so far in May and outperformed the wider market as well.

Atossa Therapeutics (ATOS) Stock More Than Doubled In a Month: What’s The Buzz?

There has been no news about the company today but considering the stock’s performance, it might be a good idea for investors to take a closer look at Atossa. Last week the company announced its financial results for the first fiscal quarter that ended on March 31, 2021.

Related:  Ocugen (OCGN) Attempts To Rebound: How Far can it Go?

At the end of the quarter, the company declared that it had no source of sustainable revenues but at the same time it did not have any cost of revenue either. Atossa recorded $137.7 million in the form of cash, restricted cash and cash equivalents at the end of the period. The total operating expenses in the first quarter stood at $3531000 as compared to expenses of $2937000 in the prior-year period.

Anthony Gonzales

Biotech, Tech, and Crypto reporter Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.